Citation Impact
Citing Papers
PD-1 + regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
2019 StandoutNobel
Aire-Dependent Thymic Development of Tumor-Associated Regulatory T Cells
2013 StandoutScienceNobel
Reading the glyco-code: New approaches to studying protein–carbohydrate interactions
2022 StandoutNobel
Re-establishing immunological self-tolerance in autoimmune disease
2012 StandoutNobel
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
CD4+CD25high T cell numbers are enriched in the peripheral blood of patients with rheumatoid arthritis
2008
Myasthenia Gravis
2016 Standout
FOXP3+ regulatory T cells: control of FOXP3 expression by pharmacological agents
2011 StandoutNobel
The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes
2013
Innate and adaptive immune cells in the tumor microenvironment
2013 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Infections in spinal instrumentation
2012
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
1999 Standout
Transforming Growth Factor-β Signaling in Immunity and Cancer
2019 Standout
Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery.
1994
Transfusion‐associated cancer recurrence and postoperative infection: meta‐analysis of randomized, controlled clinical trials
1996
Local and Distant Immunity Induced by Intralesional Vaccination with an Oncolytic Herpes Virus Encoding GM-CSF in Patients with Stage IIIc and IV Melanoma
2009
Tumors establish resistance to immunotherapy by regulating Tregrecruitment via CCR4
2020
Immunosuppressive Tumor Microenvironment in Cervical Cancer Patients
2011
Transfusion Medicine — Blood Transfusion
1999 Standout
IgG4-Related Disease
2012 Standout
Skeletal infections: microbial pathogenesis, immunity and clinical management
2022 Standout
The Cost Effectiveness of Preoperative Autologous Blood Donations
1995 Standout
FOXP3 and scurfy: how it all began
2014 StandoutNobel
Immune parameters affecting the efficacy of chemotherapeutic regimens
2011
Foxp3+ Regulatory T Cells, Th17 Effector Cells, and Cytokine Environment in Inflammatory Bowel Disease
2009
The PD‐1 pathway in tolerance and autoimmunity
2010 Standout
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Guidance of regulatory T cell development by Satb1-dependent super-enhancer establishment
2016 StandoutNobel
Circulating Naïve and CD4+CD25high Regulatory T Cells in Patients With Autoimmune Pancreatitis
2008
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Modulation of EZH2 expression in T cells improves efficacy of anti–CTLA-4 therapy
2018 StandoutNobel
The plasticity and stability of regulatory T cells
2013 StandoutNobel
FOXP3+ regulatory T cells in the human immune system
2010 StandoutNobel
Peripherally Induced Tregs – Role in Immune Homeostasis and Autoimmunity
2013
IgG4-related disease
2014 Standout
TREG-cell therapies for autoimmune rheumatic diseases
2014 StandoutNobel
The Proportion of Regulatory T Cells in Patients with Rheumatoid Arthritis: A Meta-Analysis
2016 StandoutNobel
Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity
2012
Transcription factor Ikzf1 associates with Foxp3 to repress gene expression in Treg cells and limit autoimmunity and anti-tumor immunity
2024 StandoutNobel
Regulatory T cells in cancer immunotherapy
2014 StandoutNobel
Interferon-γ Drives Treg Fragility to Promote Anti-tumor Immunity
2017
Long-term Functioning of Allogeneic Islets in Subcutaneous Tissue Pretreated With a Novel Cyclic Peptide Without Immunosuppressive Medication
2017 StandoutNobel
Neuropilin‐1 is not a marker of human Foxp3+ Treg
2009
Opportunities for Treg cell therapy for the treatment of human disease
2023 StandoutNobel
Myasthenia gravis: subgroup classification and therapeutic strategies
2015 Standout
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Genetic and epigenetic basis of Treg cell development and function: from a FoxP3‐centered view to an epigenome‐defined view of natural Treg cells
2014 StandoutNobel
Sialyl Lewis x (CD15s) identifies highly differentiated and most suppressive FOXP3 high regulatory T cells in humans
2015 StandoutNobel
Homeostasis of Thymus-Derived Foxp3+ Regulatory T Cells Is Controlled by Ultraviolet B Exposure in the Skin
2014 StandoutNobel
The Lymphatic System: Integral Roles in Immunity
2016 Standout
Neuropilin 1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth
2012 StandoutNobel
Tumor microenvironment converts plasmacytoid dendritic cells into immunosuppressive/tolerogenic cells: insight into the molecular mechanisms
2012
Biologic effects of leukocytes present in transfused cellular blood products
1994
ICOS+Foxp3+TILs in gastric cancer are prognostic markers and effector regulatory T cells associated withHelicobacter pylori
2016 StandoutNobel
Human Papillomavirus and Cervical Cancer
2003 Standout
Control of foreign Ag‐specific Ab responses by Treg and Tfr
2020 StandoutNobel
Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting
2016
Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo
2012
Immunosuppressive Effects of Blood Transfusion
1992
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
Combination therapy strategies for improving PD‐1 blockade efficacy: a new era in cancer immunotherapy
2017 StandoutNobel
Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
2014 StandoutNobel
Analysis of nanoparticle delivery to tumours
2016 Standout
Overcoming regulatory T‐cell suppression by a lyophilized preparation of Streptococcus pyogenes
2013 StandoutNobel
Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor–, granulocyte-macrophage colony-stimulating factor–, and interleukin-3–expressing NOD-SCID IL2Rγnull humanized mice
2011 StandoutNobel
Immune Checkpoint Blockade in Cancer Therapy
2015 Standout
Immunogenic Cell Death in Cancer Therapy
2012 Standout
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
2020 Standout
Works of Alexia Buzzonetti being referenced
Neuropilin‐1 expression identifies a subset of regulatory T cells in human lymph nodes that is modulated by preoperative chemoradiation therapy in cervical cancer
2007
Translational immune correlates of indirect antibody immunization in a randomized phase II study using scheduled combination therapy with carboplatin/paclitaxel plus oregovomab in ovarian cancer patients
2020
Thymopoiesis, Regulatory T Cells, and TCRVβ Expression in Thymoma With and Without Myasthenia Gravis, and Modulatory Effects of Steroid Therapy
2007
Effects of blood transfusion on the immune responsiveness and survival of cancer patients: a prospective study
1991
Circulating and thymic CD4+ CD25+ T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment
2005
Selective Changes in the Immune Profile of Tumor-Draining Lymph Nodes After Different Neoadjuvant Chemoradiation Regimens for Locally Advanced Cervical Cancer
2010
Metastatic tumour cells favour the generation of a tolerogenic milieu in tumour draining lymph node in patients with early cervical cancer
2009
Interleukin‐21 (IL ‐21) synergizes with IL ‐2 to enhance T ‐cell receptor‐induced human T‐cell proliferation and counteracts IL ‐2/transforming growth factor‐β‐induced regulatory T‐cell development
2012
Immunological response induced by abagovomab as a maintenance therapy in patients with epithelial ovarian cancer: relationship with survival—a substudy of the MIMOSA trial
2014
Relationship of blood transfusion, post-operative infections and immunoreactivity in patients undergoing surgery for gastrointestinal cancer.
1997